Alternatives to Kite Pharma

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

Developing novel immunotherapies and diagnostics for cancer.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

Biopharmaceutical company developing T-cell therapies for solid tumor cancers.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Clinical-stage biotech company targeting RNA modifications for novel cancer therapies.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

A biotechnology company focused on oncology drug discovery.